Searched for
SYNGENE IPO
First pharma IPO in 5 years: Syngene’s debut offer subscribed 32 timesThe Rs 550-crore initial public offer of Syngene, a research arm of Biocon, was subscribed 32 times on the final day of the offer31 Jul, 2015, 12.30 PM IST- Syngene IPO gets robust response; issue subscribed 32 timesThe Rs 550 crore IPO of Syngene International was over-subscribed 32.03 times on the last day of the offer today as both retail and institu...29 Jul, 2015, 10.09 PM IST
- Syngene IPO over-subscribed on second dayThe IPO got bids for 1,60,79,700 shares against 1,60,00,000 shares on offer, resulting in a subscription of 1.01 (rpt) 1.01 times, accordin...28 Jul, 2015, 09.53 PM IST
- Syngene IPO subscribed 32% on Day 1The initial public offering of biotechnology major Biocon's research arm Syngene International was subscribed 32 per cent on the first day ...27 Jul, 2015, 10.39 PM IST
- Syngene's valuations are fair, investors need to invest in its growth story: Kiran Mazumdar-ShawIn an interview with ET Now, Kiran Mazumdar-Shaw, CMD, Biocon, talks about the Syngene IPO and the growth prospects involved.27 Jul, 2015, 12.56 PM IST
- Top brokers recommend 'subscribe' to Syngene International IPO; here's whyLong-term investors should 'subscribe' to Syngene IPO which opens for subscription today, various brokerages said in a report.27 Jul, 2015, 10.23 AM IST
- Management commentary, capex outlook hold the key for Biocon: Mayuresh JoshiIf you look at how the business model has evolved for Biocon, Syngene is the one which is driving the overall profitability for the company...24 Jul, 2015, 02.33 PM IST
- Biocon sets Syngene IPO price band at Rs 240-250Biocon plans to raise Rs 550 crore by diluting 11% stake in Syngene through the Initial Public Offer. The proceeds will mostly go into fund...17 Jul, 2015, 08.27 PM IST
- Syngene IPO opens July 27; price band at Rs 240-250; Biocon shares end in redBiocon's subsidiary Syngene has set the price band for its forthcoming IPO at Rs 240-250 per share that will open on July 27.16 Jul, 2015, 05.22 PM IST
- Plan to list Syngene in August, use IPO proceeds for R&D: Kiran Mazumdar-ShawSyngene International, present in the contract services business, had filed its draft red herring prospectus (DRHP) with Sebi .24 Jun, 2015, 01.07 PM IST
- Syngene to be listed by August; IPO proceeds to be used for R&D: Kiran Mazumdar Shaw, BioconKiran Mazumdar Shaw, CMD, Biocon Ltd, tells us about the progress with the Syngene IPO and how the proceeds from the same will be used.24 Jun, 2015, 12.17 PM IST
- Syngene gets FIPB nod to raise foreign investment to 44%Syngene, a subsidiary of Biocon, said it has received the Foreign Investment Promotion Board approval to raise foreign investment to 44 per...22 Jun, 2015, 05.56 PM IST
- Analysis: Can Syngene IPO Change Biocon's Fortunes?Contributing one-fourth of the consolidated revenues, Syngene has been Biocon's best-performing segment in the last couple of years.28 Apr, 2015, 12.56 PM IST
- Biocon surges as company files prospectus for Syngene IPO to raise Rs 600 crore; ends in redBiocon surged over 3% in intraday trade on Thursday after the company filed prospectus for Syngene IPO on Wednesday to raise Rs 600 cr .23 Apr, 2015, 03.55 PM IST
- Syngene dragged too far as value proposition; avoid Biocon: Prakash DiwanWhile Syngene has a healthy pipeline of biosimilars, the monetisation of some of the molecules could take up to six years, says Diwan.01 Apr, 2015, 02.55 PM IST
- Biocon rallies on plans to list unit Syngene InternationalBiocon gained 2% in intraday trade following reports that the co plans to list its research services business arm Syngene International.01 Apr, 2015, 09.35 AM IST
- Biocon to sell up to 25% in Syngene via IPOBiocon will launch an IPO for its fully-owned contract research subsidiary Syngene this financial year.23 Apr, 2008, 03.52 AM IST
Load More
